Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
148,752
-
Share change
-
+31,670
-
Total reported value
-
$1,157,000
-
Price per share
-
$7.78
-
Number of holders
-
21
-
Value change
-
+$276,760
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2017
As of 30 Jun 2017,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
148,752 shares.
The largest 10 holders included
BARCLAYS PLC, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., Virtu KCG Holdings LLC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, ETF MANAGERS GROUP, LLC, Cutler Group LP, Sterling Investment Advisors, Ltd., and GROUP ONE TRADING, L.P..
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.